- Staat
- MI
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 10.05.2023
- Impfdatum
- 29.09.2022
- Beginn
- 02.05.2023
- Tage bis Beginn
- 215,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Anaemia
Bronchoscopy abnormal
COVID-19
Colitis
Computerised tomogram abdomen abnormal
Computerised tomogram thorax abnormal
Cytomegalovirus test
Dehydration
Diarrhoea
Haemoglobin normal
Hyperkalaemia
Lung opacity
Metabolic acidosis
Myelosuppression
Neutropenia
Occult blood positive
Red blood cell transfusion
Symptomtext
Discharge Provider: DO Primary Care Provider: MD Admission Date: 5/2/2023 Discharge Date: 5/9/23 PRESENTING PROBLEM: AKI (acute kidney injury) (HCC) [N17.9] HOSPITAL COURSE: 64 Yo male 3 months s/p bilateral lung transplasnt for COPD presented with complaints of worsening diarrhea. He was sent initially to OSH ER and found to have profound neutropenia, anemia, AKI with metabolic acidosis and hyperkalemia. CT thorax with new tree-in-bud opacities in RLL. Found to be Covid +. He was transferred to hospital for further management. A bronchoscopy was completed upon admission given CT changes which was positive for staph aureus. Patient was treated with 10d of abx, initially ancef then cefuroxime on dc. Additional his film array was positive for COVID. Given ongoing diarrhea symptoms which was thought to be related to COVID, treatment with remdesivir was completed. Regarding his severe AKI, this was felt to be likely from a combination of dehydration from diarrhea as well as severely high tacrolimus level also likely from diarrhea symptoms. Tacrolimus was held. AKI resolved completely after initiation of IVF and holding offending agents. Eventually tacrolimus was resumed without issue once kidney injury had resolved In addition to the AKI patient was severely neutropenic and anemic. He was given 1u RBC and hematology was consulted. After testing it was determined the cause was likely bone marrow suppression from toxic levels of his valcyte and tacrolimus. Patient was given 3 doses of neupogen inpatient and neutropenia recovered. Valcyte was eventually resumed 5/8 after CMV level was checked which was 0. For his anemia, EPO was given 5/7 and hemoglobin remained stable after 1u RBC. Stool occult blood was found to be positive but given stable hemologobin and known colitis on CT which can cause positive occult blood, further GI workup was not completed but this will be followed closely as an outpatient. Patient was discharged home in stable condition with plans to get outpatient labs 5/11 and be seen in clinic next week.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dehydration
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- COPD, very severe (HCC) Other specified anxiety disorders Osteopenia of multiple sites Essential hypertension Need for prophylactic antibiotic Need for pneumocystis prophylaxis Skin lesions Bilateral lung transplant Other chronic pain Steroid-induced hyperglycemia Unspecified severe protein-calorie malnutrition (HCC) Infection due to Stenotrophomonas maltophilia in native lung Achromobacter infection in native lung Immunosuppressed status (HCC) Dysphagia AKI (acute kidney injury) (HCC) Diarrhea Cough Neutropenia (HCC) Staphylococcal pneumonia (HCC) COVID
- Andere Medikamente
- azithromycin (ZITHROMAX) 250 MG tablet benzonatate (TESSALON) 100 MG capsule Blood Glucose Monitoring Suppl (ONETOUCH VERIO) w/Device KIT cefuroxime (CEFTIN) 500 mg tablet cetirizine (ZYRTEC) 10 MG tablet cholecalciferol (VITAMIN D3) 50 MCG
- Allergien
- NsaidsOther OxycodoneAgitation
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 14.02.2022
- Impfdatum
- 11.02.2022
- Beginn
- 12.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Burning sensation
Fatigue
Headache
Nausea
Chills
Cough
Pain
Pain of skin
Pyrexia
Skin burning sensation
Tachycardia
Paraesthesia
Symptomtext
Fever for 48 hours ranging from 100.1 to 100.8 Headache Fatigue Burning and tingling on entire body Weakness in joints Nausea
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tachycardia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No illness prior
- Vorgeschichte
- Ulcerative colitis, Mast Cells activation syndrome
- Andere Medikamente
- Benedryl (pre vaccine)
- Allergien
- Yeast, peanuts, rice, corn, cinnamon, hair dye
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 23.05.2022
- Impfdatum
- 10.05.2022
- Beginn
- 22.05.2022
- Tage bis Beginn
- 12,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Myalgia
Pyrexia
Rash
Rash maculo-papular
Symptomtext
Patient received 4 vaccines, reports no AEFI immediately after. At day 12 after vaccination, patient reports subjective fever, myalgias, a 5x7cm red area around VAR injection site with 5/10 pain, and a maculopapular rash (2 papules on lower back, 1 on neck). Patient also reports "bumps" on her scalp but unable to find on PE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- None reported
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 13.05.2022
- Impfdatum
- 10.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 6
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site erythema
Injection site pain
Injection site swelling
Symptomtext
redness, swelling and pain at injection site that started on 05/11/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 18.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site urticaria
Local reaction
Symptomtext
Patient returned to clinic on 04/20/22 (2 days following Tdap vaccination for a different vaccine that was needed. Patient showed injection site form Tdap and said she started to notice the red welt the day before 04/19/22. Provider and pharmacist came to assess the site and decided it was a localized reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ADHD depression meibomian gland dysfunction or upper and lower eyelids genital herpes simplex chronic idiopathic urticaria myopia of both eyes
- Andere Medikamente
- adderall yasmin valacyclovir epinephrine diphenhydramine clindamycin
- Allergien
- penicillins
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 29.03.2022
- Impfdatum
- 20.03.2022
- Beginn
- 20.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Pain in extremity
Symptomtext
Arm soreness and numbness going on 9 days not resolving.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 24.03.2022
- Impfdatum
- 23.03.2022
- Beginn
- 23.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Nausea
Pain
Retching
Symptomtext
Pt. reported acute onset nausea with dry heaves, chills and body aches. Treated originally treated with Zofran ODT, then IV fluids ( 1 L Normal Saline), IV meds: Benedryl, Pepcid and Solumedrol. 2 hrs after onset of symptoms, pt reports she is feeling better, nausea, chills and body aches resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- SKyla IUD
- Allergien
- Polymyxin B
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 21.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 18.03.2022
- Tage bis Beginn
- 2,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain
Skin warm
Swelling
Symptomtext
Severe soreness, swelling of deltoid muscle, and warm to touch of the deltoid occurred on Friday, March 18, 2022, 3 days post-vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- none
- Allergien
- losartan. procardia
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 13.03.2022
- Impfdatum
- 26.02.2022
- Beginn
- 27.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Symptomtext
patient reported arm pain from injection site that has not gone away since recieving on the shot on 2.26
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- metformin lansoprazole
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 10.03.2022
- Impfdatum
- 08.03.2022
- Beginn
- 08.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal pain
Exposure during pregnancy
Hypersensitivity
Immunisation reaction
Vomiting
Symptomtext
pt started throwing up and experiening severe abdominal pain. She is 36 weeks pregnant. ER doctor diagnosed her with allergic reaction to vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- epilepsy
- Andere Medikamente
- keppra 750mg
- Allergien
- latex and eggs
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 04.03.2022
- Beginn
- 06.03.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Decreased appetite
Fatigue
Inflammation
Pyrexia
Skin reaction
Symptomtext
Red, inflamed left arm, fever, fatigue, loss of appetite
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DIABETES
- Andere Medikamente
- OMPERAZOLE, ATORVASTATIN, LISINOPRIL, GLIPIZIDE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 24.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Eye swelling
Fatigue
Nausea
Pyrexia
SARS-CoV-2 test negative
Swelling face
Symptomtext
Pt. is a 65 Y female who reports that after she got her vaccines on 2/24 she was a little bit nauseated. She came home and felt very tired. She took a COVID test and it was negative. She started to see some swelling on the left side of the face last night. It was very pronounced and her left eye was nearly shut due to the swelling. It has gone down since yesterday. No rash. No difficulty breathing. No irritation of her throat. She did run a little fever yesterday into today. She did not take any photos. Today she feels there is still a little bit of swelling but not much.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None known
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- -
- Andere Medikamente
- None known
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 17.02.2022
- Impfdatum
- 14.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
Patient had pain, swelling, and warm to touch at injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- sickle cell trait
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 07.07.2022
- Impfdatum
- 17.05.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 15,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
PATIENT CAME INTO THE PHARMACY WITH INTENTIONS OF RECEIVING A 2ND COVID BOOSTER BUT WAS GIVEN A BOOSTRIX VACCINE. PATIENT CHECKED SYSTEM AND NOTICED THAT THE 2ND COVID BOOSTER WAS NOT AVAILABLE. PATIENT WAS DUE FOR HIS BOOSTRIX TETANUS SHOT AND WAS INFORMED TO RETURN TO PHARMACY ASAP TO GET SECOND COVID BOOSTER. PATIENT ENDED UP GETTING COVID BEFORE HE WAS ABLE TO RECIEVED HIS SECOND COVID BOOSTER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 23.06.2022
- Impfdatum
- 25.04.2022
- Beginn
- 25.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Incorrect route of product administration
Symptomtext
NURSE WAS DISTRACTED AND GAVE THE VACCINE VIA IV ROUTE, NOT IM. AFTER THIS WAS REALIZED, SHE NOTIFIED THE MD WHO SAID TO GIVE ANOTHER DOSE IM. SO PATIENT GOT 2 DOSES OF BOOSTRIX ON 4/25/22. NO ADE WAS NOTED PRIOR TO DISCHARGE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 01.04.2022
- Impfdatum
- 28.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anal incontinence
Brain scan normal
Fall
Muscle disorder
Symptomtext
Patient experience loss of muscle control and fell down on his buttocks, as well as loss of bowel control. Patient says he experienced at least 3 bowel movements. After at least 1+ hour of loss of muscle control, he was able to call for an ambulance. At the hospital, they ran a head scan and found no abnormal brain activity, so the hospital staff thinks it may be related to the vaccine he received the day before.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anal incontinence
- Hospital-Tage
- -
- Labordaten
- At the hospital, they ran a head scan and found no abnormal brain activity, so the hospital staff thinks it may be related to the vaccine he received the day before.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HIV INFECTION, MIGRAINE, PRURITIS, VERTEBRAL DISK DISEASE
- Andere Medikamente
- -
- Allergien
- ASPIRIN
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 22.03.2022
- Impfdatum
- 18.03.2022
- Beginn
- 18.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Epistaxis
Haematochezia
Symptomtext
Patient reported bloody nose on Friday night. It didn't stop bleeding for about 45 minutes. Patient also reported blood in stool. Pt states that he does not have a hx of bloody nose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Epistaxis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Losartan, Levothyroxine, Albuterol
- Allergien
- Spinach, Wheat
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 08.03.2022
- Impfdatum
- 02.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Boostrix administered after temp excur; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 30-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number N254C, expiry date 23rd November 2023) for prophylaxis. On 2nd March 2022, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional details were reported as follows: The reporter reported that Boostrix underwent above temperature excursion with high 67 Fahrenheit for 14 days and was administered to a patient, which let to Incorrect storage of drug. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. This is 1 of the 6 cases reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2022040251:Same reporter US-GLAXOSMITHKLINE-US2022040252:Same reporter US-GLAXOSMITHKLINE-US2022040254:Same reporter US-GLAXOSMITHKLINE-US2022040246:Same reporter US-GLAXOSMITHKLINE-US2022040248:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 02.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
boostrix underwent above temp excur and was administered; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 26-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number n254c, expiry date 23rd November 2023) for prophylaxis. On 2nd March 2022, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional details were reported as follows: The reporter reported that the Boostrix underwent above temperature excursion with high: 67 F time: 14 days and was administered to the patient, which let to incorrect storage of drug. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. This was 1 of the 6 cases reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2022040253:Same reporter US-GLAXOSMITHKLINE-US2022040254:Same reporter US-GLAXOSMITHKLINE-US2022040251:Same reporter US-GLAXOSMITHKLINE-US2022040252:Same reporter US-GLAXOSMITHKLINE-US2022040248:same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Dose administered to 3 year old patient; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number n254c, expiry date 23rd November 2023) for prophylaxis. On 18th February 2022, the patient received Boostrix. On 18th February 2022, unknown after receiving Boostrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional details were provided as follows: The patient was inadvertently administrated a dose of Boostrix, which led to inappropriate age at vaccine administration. No further events were reported. The reporter agreed to be contacted for follow-up The Vaccine Administration Facility is the same as Primary Reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 19.02.2022
- Impfdatum
- 29.01.2022
- Beginn
- 29.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
dose in 2021 received another dose; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 26-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number N254C, expiry date 23rd November 2023) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included Boostrix with an associated reaction of exposure during pregnancy (received 1st dose during pregnancy, refer linked case US2022016944). On 29th January 2022, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 29th January 2022, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The Medical Assistant reported that, a pregnant patient received a dose of Boostrix in September 2021 and delivered on 14th November 2021. The patient returned for her postpartum visit on 29th January 2022 and received another dose of Boostrix, which led to extra dose administered. The reporter consented to follow up. The Vaccine Administration Facility is the same as Primary Reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2022016944:Same reporter and patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -